Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131765996> ?p ?o ?g. }
- W2131765996 endingPage "626" @default.
- W2131765996 startingPage "618" @default.
- W2131765996 abstract "<i>N</i>-Methyl-d-aspartate (NMDA) receptor antagonists that are highly selective for specific NMDA receptor 2 (NR2) subunits have several potential therapeutic applications; however, to date, only NR2B-selective antagonists have been described. Whereas most glutamate binding site antagonists display a common pattern of NR2 selectivity, NR2A > NR2B > NR2C > NR2D (high to low affinity), (2<i>S</i>*,3<i>R</i>*)-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid (PPDA) has a low selectivity for NR2C- and NR2D-containing NMDA receptors. A series of PPDA derivatives were synthesized and then tested at recombinant NMDA receptors expressed in <i>Xenopus laevis</i> oocytes. In addition, the optical isomers of PPDA were resolved; the (−) isomer displayed a 50- to 80-fold greater potency than the (+) isomer. Replacement of the phenanthrene moiety of PPDA with naphthalene or anthracene did not improve selectivity. However, phenylazobenzoyl (UBP125) or phenylethynylbenzoyl (UBP128) substitution significantly improved selectivity for NR2B-, NR2C-, and NR2D-containing receptors over NR2A-containing NMDA receptors. Phenanthrene attachment at the 3 position [(2<i>R</i>*,3<i>S</i>*)-1-(phenanthrene-3-carbonyl)piperazine-2,3-dicarboxylic acid (UBP141); (2<i>R</i>*,3<i>S</i>*)-1-(9-bromophenanthrene-3-carbonyl)piperazine-2,3-dicarboxylic acid (UBP145); (2<i>R</i>*,3<i>S</i>*)-1-(9-chlorophenanthrene-3-carbonyl)piperazine-2,3-dicarboxylic acid (UBP160); and (2<i>R</i>*,3<i>S</i>*)-1-(9-iodophenanthrene-3-carbonyl)piperazine-2,3-dicarboxylic acid (UBP161)] displayed improved NR2D selectivity. UBP141 and its 9-brominated homolog (UBP145) both display a 7- to 10- fold selectivity for NR2D-containing receptors over NR2B- or NR2A-containing receptors. Schild analysis indicates that these two compounds are competitive glutamate binding site antagonists. Consistent with a physiological role for NR2D-containing receptors in the hippocampus, UBP141 (5 μM) displayed greater selectivity than PPDA for inhibiting the slow-decaying component of the NMDA receptor-mediated CA3-CA1 synaptic response in rat hippocampal slices. UBP125, UBP128, UBP141, and UBP145 may be useful tools for determining the function of NMDA receptor subtypes." @default.
- W2131765996 created "2016-06-24" @default.
- W2131765996 creator A5002091267 @default.
- W2131765996 creator A5011370949 @default.
- W2131765996 creator A5029957711 @default.
- W2131765996 creator A5039824894 @default.
- W2131765996 creator A5042844182 @default.
- W2131765996 creator A5050274341 @default.
- W2131765996 creator A5058016799 @default.
- W2131765996 creator A5068235733 @default.
- W2131765996 creator A5087391939 @default.
- W2131765996 date "2009-08-14" @default.
- W2131765996 modified "2023-10-03" @default.
- W2131765996 title "<i>N</i>-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse" @default.
- W2131765996 cites W1483876599 @default.
- W2131765996 cites W1505115830 @default.
- W2131765996 cites W1594111906 @default.
- W2131765996 cites W1600539804 @default.
- W2131765996 cites W1646272776 @default.
- W2131765996 cites W1898323316 @default.
- W2131765996 cites W1908222510 @default.
- W2131765996 cites W1971235606 @default.
- W2131765996 cites W1972183007 @default.
- W2131765996 cites W1984148607 @default.
- W2131765996 cites W2001189298 @default.
- W2131765996 cites W2008188786 @default.
- W2131765996 cites W2016651165 @default.
- W2131765996 cites W2017329375 @default.
- W2131765996 cites W2021342314 @default.
- W2131765996 cites W2032008843 @default.
- W2131765996 cites W2037141564 @default.
- W2131765996 cites W2044604492 @default.
- W2131765996 cites W2063541383 @default.
- W2131765996 cites W2065169750 @default.
- W2131765996 cites W2074631079 @default.
- W2131765996 cites W2076815251 @default.
- W2131765996 cites W2078662595 @default.
- W2131765996 cites W2090590009 @default.
- W2131765996 cites W2091765514 @default.
- W2131765996 cites W2098990756 @default.
- W2131765996 cites W2114091391 @default.
- W2131765996 cites W2120048206 @default.
- W2131765996 cites W2126094338 @default.
- W2131765996 cites W2138643360 @default.
- W2131765996 cites W2146240668 @default.
- W2131765996 cites W2152072736 @default.
- W2131765996 cites W2154178019 @default.
- W2131765996 cites W2157035049 @default.
- W2131765996 cites W2172060122 @default.
- W2131765996 cites W947361586 @default.
- W2131765996 doi "https://doi.org/10.1124/jpet.109.156752" @default.
- W2131765996 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2775268" @default.
- W2131765996 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19684252" @default.
- W2131765996 hasPublicationYear "2009" @default.
- W2131765996 type Work @default.
- W2131765996 sameAs 2131765996 @default.
- W2131765996 citedByCount "47" @default.
- W2131765996 countsByYear W21317659962012 @default.
- W2131765996 countsByYear W21317659962013 @default.
- W2131765996 countsByYear W21317659962014 @default.
- W2131765996 countsByYear W21317659962015 @default.
- W2131765996 countsByYear W21317659962016 @default.
- W2131765996 countsByYear W21317659962017 @default.
- W2131765996 countsByYear W21317659962018 @default.
- W2131765996 countsByYear W21317659962019 @default.
- W2131765996 countsByYear W21317659962020 @default.
- W2131765996 countsByYear W21317659962021 @default.
- W2131765996 countsByYear W21317659962022 @default.
- W2131765996 countsByYear W21317659962023 @default.
- W2131765996 crossrefType "journal-article" @default.
- W2131765996 hasAuthorship W2131765996A5002091267 @default.
- W2131765996 hasAuthorship W2131765996A5011370949 @default.
- W2131765996 hasAuthorship W2131765996A5029957711 @default.
- W2131765996 hasAuthorship W2131765996A5039824894 @default.
- W2131765996 hasAuthorship W2131765996A5042844182 @default.
- W2131765996 hasAuthorship W2131765996A5050274341 @default.
- W2131765996 hasAuthorship W2131765996A5058016799 @default.
- W2131765996 hasAuthorship W2131765996A5068235733 @default.
- W2131765996 hasAuthorship W2131765996A5087391939 @default.
- W2131765996 hasBestOaLocation W21317659962 @default.
- W2131765996 hasConcept C118792377 @default.
- W2131765996 hasConcept C161790260 @default.
- W2131765996 hasConcept C170493617 @default.
- W2131765996 hasConcept C178790620 @default.
- W2131765996 hasConcept C185592680 @default.
- W2131765996 hasConcept C2776201271 @default.
- W2131765996 hasConcept C2776568683 @default.
- W2131765996 hasConcept C55493867 @default.
- W2131765996 hasConcept C67018056 @default.
- W2131765996 hasConcept C71240020 @default.
- W2131765996 hasConceptScore W2131765996C118792377 @default.
- W2131765996 hasConceptScore W2131765996C161790260 @default.
- W2131765996 hasConceptScore W2131765996C170493617 @default.
- W2131765996 hasConceptScore W2131765996C178790620 @default.
- W2131765996 hasConceptScore W2131765996C185592680 @default.
- W2131765996 hasConceptScore W2131765996C2776201271 @default.
- W2131765996 hasConceptScore W2131765996C2776568683 @default.
- W2131765996 hasConceptScore W2131765996C55493867 @default.